FRANK LLOYD: Open Payments
NPI 1740364645 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$868 in 37 payments from 9 companies in 2025. Trend: 2023 $847 · 2024 $1,301 · 2025 $868
Food & beverage: $868
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $329 |
| Braeburn Inc. | 8 | $228 |
| Otsuka America Pharmaceutical, Inc. | 5 | $113 |
| Gilead Sciences, Inc. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Indivior Inc. | 1 | $18 |
| Orexo US, Inc. | 1 | $15 |
Products named: MAVYRET, BRIXADI, REXULTI, SPRAVATO, CAPLYTA, Auvelity, SUBLOCADE, Zubsolv.
Industry payments across IN — which companies pay providers there.
